IDH1/2 and FLT3-IDT mutations in AML lead to abnormalities in ROS, lipid metabolism, and increased susceptibility to ferroptosis, but it was not found whether these two mutations affect iron metabolism, which can be further explored as a direction for future research. This evidence concerns the gene FLT3 and acute myeloid leukemia.